🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Food and Drug Administration Approval of Tenecteplase: What This Means for the Field of Acute Stroke Treatment | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV…

Early DOAC Initiation Might Be Safe After Reperfusion Therapy in Patients With Acute Ischemic Stroke and Atrial Fibrillation | AHA Blogs ahajournals.org/do/10.1161/blo…

Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial | Stroke ahajournals.org/doi/full/10.11…

Does the Burden of CSVD Modify the Efficacy of Dual Antiplatelet Therapy?: A Post Hoc Analysis of the INSPIRES Trial | Stroke ahajournals.org/doi/10.1161/ST…

Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale | Stroke ahajournals.org/doi/10.1161/ST…

Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy | Stroke ahajournals.org/doi/10.1161/ST…

Changing Management of Focal Cerebral Arteriopathy of Childhood From 2010 to 2022 | Stroke ahajournals.org/doi/10.1161/ST…

Fresh DISTAL and ESCAPE-MeVO analyses further elucidate stroke thrombectomy’s role in distal-vessel occlusions neuronewsinternational.com/fresh-distal-a…

Preventive Effects of Prasugrel on Cerebrovascular Events Following Percutaneous Coronary Intervention | Stroke ahajournals.org/doi/10.1161/ST…

Fibrinogen Depletion Coagulopathy and Hemorrhagic Transformation in Acute Ischemic Stroke Treated With Bridging Therapy | Stroke ahajournals.org/doi/10.1161/ST…

PCSK9 inhibitors could be very useful for reducing the rate of major vascular events in patients with symptomatic intracranial disease. Strong work by J Siegler in leading this analysis Neurology Journal Shadi Yaghi Malik Ghannam World Stroke Org neurology.org/doi/10.1212/WN…

Every 10 mg/dL ⬇️ in LDL for patients with ICAD stroke has 9% ⬇️ rates of recurrent stroke or MI. this theoretical framework suggests that PCSK9i can help achieve this. We need PCSK-9i trials in ICAD Jim Siegler (@jimsieglermd.bsky.social now) Tareq Kass-Hout Malik Ghannam Seemant Chaturvedi neurology.org/doi/10.1212/WN…

A study focuses on the benefits of further lowering of LDL in ICAD to prevent recurrent strokes. PCSK9 inhibitors may offer a promising strategy to achieve such goal. ⁦⁦Jim Siegler (@jimsieglermd.bsky.social now)⁩ ⁦Shadi Yaghi⁩ ⁦Seemant Chaturvedi⁩ ⁦Tareq Kass-Hout⁩ neurology.org/doi/10.1212/WN…

Generalized myasthenia gravis with acetylcholine receptor antibodies: a guidance for treatment onlinelibrary.wiley.com/doi/full/10.11…

Vascular territories & stroke patterns on MRI. #MEDed #FOAMed #RADed #FOAMrad #radres #neurorad

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Nontraumatic Intracerebral Hemorrhage in Patients With Type 2 Diabetes | Stroke ahajournals.org/doi/10.1161/ST…

An official welcome to our assistant editor ⁦Aaron Shoskes⁩ ⁦Stroke AHA/ASA⁩ ⁦UMiamiStroke⁩ podcasts.apple.com/us/podcast/str…

I’m honored to have received the 2025 Faculty Teaching Award. Thank you to the University of Iowa and to the incredible residents—it’s been a privilege to teach and learn alongside you. I’ve truly enjoyed every moment. ⁦Iowa Neurology⁩ ⁦Iowa Vascular⁩

Intra‐Arterial Thrombolysis After Mechanical Thrombectomy in Patients with Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV…